Elanco

We’re celebrating spooky season with a parasite’s worst nightmare. Today, the U.S. Food and Drug Administration (FDA) approves Credelio QuattroTM (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) becoming the broadest* approved canine oral parasiticide with its protection against six types of parasites—fleas, ticks, heartworms, and the three risky intestinal parasites—roundworms, hookworms** and tapeworms in a single monthly chewable tablet for dogs eight weeks of age or older and weighing 3.3 pounds or greater. ?Starts to kill ticks*** and fleas in just 4 hours. ??Kills >99% of fleas within 8 hours of administration and 100% in the first day and remains effective for an entire month. ??Provides coverage against internal parasites with zoonotic potential, meaning parasites that have the potential to infect people as well as pets, it’s very easy to go from ‘ick’ to ‘sick.’ 4?? Credelio Quattro is the newest addition to the Credelio? (lotilaner) franchise and the first FDA-approved parasiticide product with four active ingredients. Learn more about Credelio Quattro: https://lnkd.in/g4VXUWJp #WeAreElanco Indications: Credelio Quattro is for the prevention of heartworm disease for the treatment and control of roundworm, hookworm** and tapeworm infections. Credelio Quattro kills adult fleas and is for the treatment and prevention of flea infestations and the treatment and control of tick infestations for 1 month in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater. Important Safety Information: Lotilaner, an ingredient in Credelio Quattro, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, ataxia, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro administration as it is not effective against adult D. immitis. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea. For complete safety information, please see Credelio Quattro product label or ask your veterinarian, https://lnkd.in/gnAA5gY4. *Based on label comparison of number of parasites types covered. ** Uncinaria stenocephala *** Ixodes ricinus

The time to deliver new science-based solutions is now… and we’re starting with the cow. Feeding a growing population while reducing greenhouse gas emissions requires: ? Science-based approaches ? Scalable solutions ? Supply chain partnerships On October 8-9, our team will be at Reuters Transform Food & Agriculture in Minneapolis to discuss the latest initiatives, products and partnerships that can help the dairy supply chain reduce, measure and monetize enteric methane emissions. Katie Cook, VP of Livestock Sustainability and U.S. Farm Animal Marketing, will be speaking with Dairy Farmers of America about the future of food and show that the cow can be how. If you’re attending this event, drop us a message to connect on-site. https://bit.ly/4eQSBNf

Lions, tigers and… 100,000 meals?! Oh, my! Today our Indianapolis team is celebrating our annual Global Day of Purpose, kicking off a month of giving and volunteerism. More than 500 volunteers from the local team are spending the day at the Indianapolis Zoo with Rise Against Hunger packing 100,000 meals- making this the largest meal packing event in Indiana. With employee-driven events around the world today and throughout the month, our team is committed to building healthier communities for people and animals. #GDOP2024 #WeAreElanco

When it comes to battling allergic dermatitis, little Trooper certainly earned his name. Trooper, a year-old Yorkshire Terrier, suffered from allergic dermatitis and was experiencing year-around itching that was impacting his quality of life and keeping him from normal puppy play. His owner and veterinarian tried multiple treatment options, but nothing worked to their satisfaction…Until he was enrolled as a participant in the Zenrelia? (ilunocitinib tablets) clinical trial. During the clinical trial, Trooper overcame his battle with allergic itch. He started the trial with an itch level of 10/10 on the PVAS (pruritus visual analog scale) and by the end of the trial, he was at a 1.1, with anything below a 2 being a normal level of itch. There’s a new allergic itch treatment and it’s helping dogs – like Trooper – reach for Zen. Learn more at ZenreliaForVets.com. #WeAreElanco See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit https://lnkd.in/gsYNzUhM. ? ? WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Dogs should not take Zenrelia for a time period before and after vaccination. Discuss your dog’s vaccine schedule with your veterinarian.

For more than two decades, we have worked with key stakeholders and customers across the food chain supporting reductions in the use of medically important antibiotics and bringing new prevention tools to market. This includes supporting initiatives that develop a broad ranging consensus for better animal health and disease prevention, alongside actions in human health and environment, as an important pathway to address antimicrobial resistance (AMR) in a One Health context. Last week, the United Nations passed its 2nd Political Declaration on Antimicrobial Resistance (AMR) and providing leadership on global action against AMR. We welcome the United Nations and their leadership toward creating a global consensus in three areas: - Disease prevention: Commitment for all nations to have animal vaccination strategies with defined implementation plans by 2030, recognizing “the need to prioritize and fund the implementation to prevent and control infections.” - Science-based solutions: Call for creation of an ‘independent panel’ that can provide the scientific evidence necessary to address AMR in a One Health manner. - Access to animal health tools: Commitment to “promote the timely supply of quality and affordable essential veterinary medicines, vaccines and diagnostics”, acknowledging the need to improve diagnostic use and increase the number of veterinarians, veterinary paraprofessionals and paraprofessionals globally. We will continue working with governments and stakeholders to implement key parts of the Declaration important to our industry including, continued promotion of responsible use of antimicrobials, strengthening and investment in animal health systems and research, develop and market products and services which help reduce the need for medically important antibiotics including vaccines and nutritional products. #WeAreElanco Photo Courtesy: UN Photo/Mark Garten

New technologies ?? livestock sustainability Last week our team took part in key #ClimateWeek discussions talking about the future of animal agriculture and the path towards climate neutral farming. The key? Technologies and science-based research. President and CEO, Jeff Simmons, spoke with state agriculture leaders at the NASDA conference on cultivating technology in agriculture. One health solutions - where human, animal and environmental health converge - require science-backed research to help guide and regulate the industry toward a more sustainable future. Jesse Sevcik, Global Public Affairs, Policy and Sustainability, presented at the Global Dairy Platform and Global Roundtable for Sustainable Beef event to discuss how through innovative technologies, livestock can play a key role in tackling the reduction of enteric methane. As we look to tackle some of the most pressing climate challenges, new technology and livestock must work hand-in-hand to help pave the way. #WeAreElanco

Want to hear a secret? You can enjoy a burger without the misperceived guilt! The cow can be how we help solve global challenges -- from feeding a growing world population high quality protein to reducing the environmental impact. In a recent article with Fast Co, Jeff Simmons, President and CEO, discusses how the cow’s environmental footprint is changing, putting us on a path to climate neutral livestock farming in this decade. So go ahead, order that burger, in fact, make it a cheeseburger. #WeAreElanco #ClimateWeek https://bit.ly/4eyHd8H

Cows and #ClimateWeek can co-exist. Earlier this year, we experienced the warmest day in Earth's recorded history. The most efficient opportunity to mitigate warming? Methane. - Methane is 27 x more potent than carbon dioxide at trapping heat - So small reductions create a greater impact on temperature Check out a conversation with our CEO and a leading climate expert to learn more. https://bit.ly/3zurDMp

This is the moment we have been itching for! Today, we announced the U.S. Food and Drug Administration (FDA) has approved Zenrelia? (ilunocitinib tablets), a safe, highly effective, and convenient once-daily oral JAK inhibitor for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Itching is one of the top reasons pet owners bring their dogs to the veterinarian with approximately 17 million dogs in the U.S. suffering from allergic skin disease, including atopic dermatitis, food allergies or flea sensitivity.(1) The approval of Zenrelia represents an important advancement in treating itchy dogs suffering from chronic, acute or seasonal itch and inflammation in a single, once daily tablet from the start. Today’s announcement makes us just the second animal health company, with a comprehensive portfolio including parasiticides, vaccines, pain and other therapeutics, and now, dermatology. Read more here: https://bit.ly/Zenrelia #WeAreElanco #Innovation #PetHealth Sources: (1)AVMA Sourcebook. Elanco, Dermatology Products SOV Study, 2023 See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit https://lnkd.in/gsYNzUhM. WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Dogs should not take Zenrelia for a time period before and after vaccination. Discuss your dog’s vaccine schedule with your veterinarian.

Each year, an estimated 330,000(1) dogs are diagnosed with canine parvovirus — one of the deadliest viruses a dog can contract — resulting in up to a 91%(2) mortality rate without supportive care. A patient with parvovirus can be exhausting and stressful for clinic staff. But with our USDA-conditionally approved Canine Parvovirus Monoclonal Antibody, veterinarians are seeing real, effective results. #WeAreElanco 1: Elanco. Data on File. 2: Venn EC, JVET Emerg Crit Care. 2017.